首页|乳腺癌微钙化与PTX3、BMP2蛋白表达的相关性研究

乳腺癌微钙化与PTX3、BMP2蛋白表达的相关性研究

扫码查看
目的 探究乳腺癌微钙化与五聚蛋白3(PTX3)、骨形态发生蛋白2(BMP2)蛋白表达的相关性.方法 选择2018年7月至2020年7月邯郸市中心医院收治的乳腺癌患者143例为研究对象,根据乳腺癌超声检查微钙化情况,将其分为微钙化组(n=87)、无微钙化组(n=56).采用免疫组织化学法检测PTX3、BMP2蛋白表达水平;采用Kaplan-Meier法分析PTX3、BMP2表达与乳腺癌微钙化患者预后的关系;多因素Cox回归分析乳腺癌微钙化患者预后的影响因素.结果 微钙化组肿瘤直径>5 cm、TNM分期Ⅲ~Ⅳ期、淋巴结转移比例均显著高于无微钙化组(P<0.05).微钙化组PTX3、BMP2阳性表达率(65.52%,71.26%)均显著高于无微钙化组阳性表达率(39.29%,48.21%)(P<0.05).乳腺癌微钙化患者血清PTX3阳性表达患者3年生存率(31.58%)低于PTX3阴性表达患者(76.67%)(log rank x2=19.583,P<0.05);乳腺癌微钙化患者血清BMP2阳性表达患者3年生存率(33.87%)低于BMP2阴性表达患者(80.00%)(log rank x2=16.556,P<0.05).PTX3、BMP2、TNM分期、肿瘤直径、淋巴结转移是乳腺癌微钙化患者预后的影响因素(P<0.05).结论 乳腺癌微钙化患者PTX3、BMP阳性表达率明显升高,其与乳腺癌微钙化患者TNM分期、肿瘤直径、淋巴结转移联系紧密,是乳腺癌微钙化患者预后的影响因素.
Correlation between microcalcification with expression of PTX3,BMP2 proteins in breast cancer
Objective To investigate the correlation between microcalcification with the expression of pentraxin-3(PTX3),bone morphogenetic protein 2(BMP2)proteins in breast cancer.Methods A total of 143 patients with breast cancer who accepted by Handan Central hospital from July 2018 to July 2020 were regarded as the study subjects.According to the microcalcifications of breast cancer detected by ultrasound,they were separated into microcalcification group(n=87)and non microcalcification group(n=56).Immunohistochemical methods were applied to detect the expression levels of PTX3 and BMP2 proteins.Kaplan-Meier method was applied to analyze the relationship between the expression of PTX3,BMP2 with the prognosis of breast cancer patients with microcalcification.Multivariate Cox regression was used to analyze the prognostic factors of breast cancer patients with micro-calcification.Results The proportions of tumor diameter>5 cm,TNM stage Ⅲ-Ⅳ,and lymph node metastasis in the microcalcifica-tion group were obviously higher than those in the non microcalcification group(P<0.05).The positive expression rates of PTX3 and BMP2 in the microcalcification group(65.52%,71.26%)were obviously higher than those in the non microcalcification group(39.29%,48.21%)(P<0.05).The 3-year survival rate of patients with positive serum PTX3 expression(31.58%)was lower than that of patients with negative PTX3 expression(76.67%)(log rank x2=19.583,P<0.05);the 3 year-survival rate of patients with positive serum BMP2 expression(33.87%)was lower than that of patients with negative BMP2 expression(80.00%)(log rank x2=16.556,P<0.05).PTX3,BMP2,TNM stage,tumor diameter,and lymph node metastasis were the prognostic factors of breast cancer patients with microcalcification(P<0.05).Conclusion The positive expression rates of PTX3 and BMP in breast cancer patients with micro-calcification are obviously higher,which are closely related to the TNM stage,tumor diameter and lymph node metastasis of breast cancer patients with microcalcification,and are influential factors for the prognosis of breast cancer patients with microcalcification.

pentraxin-3bone morphogenetic protein 2breast cancer microcalcification

夏利敏、霍永平、马祥敏、陈世豪

展开 >

邯郸市中心医院乳腺外科,河北邯郸 056001

五聚蛋白3 骨形态发生蛋白2 乳腺癌微钙化

2024

中国优生与遗传杂志
中国优生科学协会

中国优生与遗传杂志

CSTPCD
影响因子:0.527
ISSN:1006-9534
年,卷(期):2024.32(11)